Latest Society for Cardiovascular Angiography and Interventions Stories

ACE Accreditation and E3: More Than Peer Review Services to showcase cardiac cath lab AUC expertise. Washington, DC (PRWEB) May 02, 2013 The Accreditation for Cardiovascular Excellence (ACE), an independent organization sponsored by the Society for Cardiovascular Angiography and Interventions (SCAI) and ACCF, will join forces with the robust education and quality initiatives to be held during the SCAI Scientific Sessions in Orlando, Florida, May 8-10, 2013. The sessions provide an...

Study published in the Journal of American Medical Association (JAMA) Surgery shows percutaneous coronary intervention (PCI) drove cost savings WASHINGTON, March 21, 2013 /PRNewswire/ -- Minimally invasive procedures significantly lower health payer costs and result in fewer missed work-days when compared to open surgery, according to a study published this week in the Journal of the American Medical Association (JAMA) Surgery. Of six procedures examined, the percutaneous coronary...

Debuting at SCAI 2013, Track Will Provide Forum for Continued Leadership in Patient Safety and Quality Care WASHINGTON, March 4, 2013 /PRNewswire/ -- A first-of-its-kind educational track devoted to quality improvement will debut at the 2013 Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI), May 8-11, in Orlando, Fla. The new track will provide a forum for discussion of topics impacting the future of health care in the United States, such as...

WASHINGTON, Oct. 17, 2012 /PRNewswire/ -- Today, the Society for Cardiovascular Angiography and Interventions (SCAI) announced results from a new survey that found four out of five (81 percent) patients say their lives have changed for the better following angioplasty, a procedure to open blocked arteries and allow blood to circulate freely. Simultaneously, SCAI published a comprehensive review of research on quality of life following angioplasty and stenting. The paper offers...

CCI President’s page connects Appropriate Use Criteria (AUC) and Cath Lab Accreditation. Washington, DC (PRWEB) September 24, 2012 In the September, 2012 CCI President’s Page, J. Jeffrey Marshall, MD, FSCAI, President of the Society for Cardiovascular Angiography and Interventions (SCAI), shared his opinion on the need to accredit cath labs through ACE, the Accreditation for Cardiovascular Excellence. “...I want to focus on what individual practicing interventionalists can do to...

WASHINGTON, Sept. 10, 2012 /PRNewswire/ -- Coronary revascularization appropriate use criteria (AUC) are now just a click away with the new SCAI Quality Improvement Toolkit (SCAI-QIT) AUC and Guidelines App, launched today by the Society for Cardiovascular Angiography and Interventions (SCAI). "The new app is a calculator tool that makes it simple to access the AUC on heart revascularization without having to carry around printed documents," said Kalon Ho, MD, FSCAI, architect of...

WASHINGTON, Aug. 28, 2012 /PRNewswire/ -- The FAME 2 trial will improve treatment strategies for patients with stable ischemic heart disease. FAME 2 indicates that angioplasty and stenting (also known as percutaneous coronary intervention, or PCI) plus the best available medications results in better outcomes than medications alone for patients who have significant blockages in their heart arteries, as measured by a test known as Fractional Flow Reserve (FFR). With these results,...

LAS VEGAS, May 10, 2012 /PRNewswire/ -- An investigational therapy derived from a patient's own bone marrow stem cells improves heart function in some patients with progressive heart failure due to dilated cardiomyopathy (DCM), according to the results of a Phase 2a study presented today as a late-breaking clinical trial at the SCAI 2012 Scientific Sessions. Ixmyelocel-T is developed by culturing a patient's bone marrow for 12 days to increase the numbers of immune cells including...

LAS VEGAS, May 10, 2012 /PRNewswire/ -- A robotic system can safely assist interventional cardiologists in performing percutaneous coronary interventions (PCI) while significantly reducing the physician's exposure to radiation and improving precision and control, according to results of the PRECISE study (CorPath Percutaneous Robotically-Enhance Coronary Intervention Study), presented today as a late-breaking clinical trial at the SCAI 2012 Scientific Sessions. During traditional...

LAS VEGAS, May 10, 2012 /PRNewswire/ -- Two types of stent systems are both effective in treating patients who have severe forms of peripheral artery disease (PAD), according to results of the MOBILITY trial presented today as a late-breaking clinical trial at the SCAI 2012 Scientific Sessions. The study found patients with complex lesions who were treated with a balloon-expandable stent system, in which a balloon-tipped catheter is inflated to expand and place the stent, or a...